Rimini Street wins court ruling over $58.5 million fee dispute

Rimini Street (RMNI) announced that the U.S. District Court vacated its prior order awarding Oracle (ORCL) approximately $58.5 million in attorneys’ fees and costs, following a remand from the Ninth Circuit in the "Rimini II" litigation; this reverses a previous ruling in favor of Oracle. Separately, Rimini Street reported Q1 2025 revenue of $104.2 million, slightly above expectations, but missed EPS forecasts, while gross margin improved to 61%; the company also appointed Vijay Kumar as COO and is partnering with Apsen Farmacêutica and ServiceNow to enhance Apsen's ERP system. Despite these developments, formal guidance remains suspended due to ongoing litigation with Oracle.

Analysis

Rimini Street (NASDAQ:RMNI) has achieved a significant positive development in its protracted legal battle with Oracle (NYSE:ORCL), with the U.S. District Court for the District of Nevada vacating a prior order that had awarded Oracle approximately $58.5 million in attorneys’ fees and costs. This ruling, following a remand from the U.S. Court of Appeals for the Ninth Circuit, materially alleviates a considerable financial liability and legal overhang for the $295 million market cap enterprise software support provider, whose stock has already appreciated over 50% in the past six months. Despite this legal victory, formal guidance remains suspended due to the ongoing litigation. Operationally, Rimini Street reported Q1 2025 revenue of $104.2 million, marginally exceeding consensus estimates of $103.26 million, and demonstrated an improved gross margin of 61%, up from 59.8% in the prior year. However, earnings per share (EPS) for the quarter came in at $0.04, missing the anticipated $0.07. Strategic initiatives include the appointment of Vijay Kumar as Chief Operating Officer, bringing over 25 years of enterprise software experience, and a new collaboration with Apsen Farmacêutica and ServiceNow (NYSE:NOW) to enhance Apsen’s ERP system, underscoring Rimini Street's value proposition of significant cost reduction and extended software lifecycles. InvestingPro analysis indicates the company is currently undervalued, with analyst price targets ranging from $4 to $7, suggesting potential upside beyond the recent stock surge.

Key Decisions for Investors

• Investors should view the vacated $58.5 million award as a substantial de-risking event for Rimini Street, potentially improving its financial flexibility and reducing litigation-related uncertainty, which has been a major overhang.
• Monitor for any further developments in the 'Rimini II' litigation with Oracle, as its complete resolution could lead to the reinstatement of formal financial guidance and further re-rate the stock.
• Evaluate the company's ability to translate its improved gross margin and strategic partnerships, like the one with Apsen Farmacêutica, into consistent EPS growth, particularly given the recent Q1 EPS miss, while considering the positive analyst sentiment and perceived undervaluation.